Tg Therapeutics (TGTX) Long-Term Investments (2013 - 2026)

Tg Therapeutics' Long-Term Investments history runs 9 years deep, the most recent figure standing at $61.5 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 3126.95% year-over-year to $61.5 million; the TTM figure through Mar 2026 stood at $61.5 million (up 3126.95% YoY), while the FY2025 annual figure was $59.1 million, up 7218.81% from the prior year.
• Long-Term Investments was $61.5 million for Q1 2026 at Tg Therapeutics, up from $59.1 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $61.5 million in Q1 2026 to a low of $808000.0 in Q4 2024.
• Historically, Long-Term Investments has averaged $24.8 million across 4 years, with a median of $21.8 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Long-Term Investments sank 65.09% in 2022, then jumped 7218.81% in 2025.
• A 4-year view of Long-Term Investments shows it stood at $12.4 million in 2022, then tumbled by 93.49% to $808000.0 in 2024, then surged by 7218.81% to $59.1 million in 2025, then grew by 4.06% to $61.5 million in 2026.
• The last three Long-Term Investments figures came in at $61.5 million (Q1 2026), $59.1 million (Q4 2025), and $48.8 million (Q3 2025), per Business Quant data.